MELFI, ROSETTA
 Distribuzione geografica
Continente #
AS - Asia 565
NA - Nord America 438
EU - Europa 189
OC - Oceania 2
AF - Africa 1
Totale 1.195
Nazione #
SG - Singapore 468
US - Stati Uniti d'America 437
CN - Cina 71
IT - Italia 50
CZ - Repubblica Ceca 41
DE - Germania 31
GB - Regno Unito 26
NL - Olanda 21
HK - Hong Kong 17
IN - India 6
FI - Finlandia 5
FR - Francia 4
AU - Australia 2
LT - Lituania 2
NO - Norvegia 2
SE - Svezia 2
AL - Albania 1
CA - Canada 1
EE - Estonia 1
ID - Indonesia 1
IR - Iran 1
LU - Lussemburgo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 1.195
Città #
Ashburn 308
Singapore 54
Boardman 38
Brno 32
Hefei 28
Rome 28
London 25
Hong Kong 15
Shanghai 15
Amsterdam 14
Munich 14
Council Bluffs 13
Olomouc 9
Washington 9
West Jordan 8
Los Angeles 6
San Francisco 6
Bengaluru 4
Hanover 4
Helsinki 4
Nuremberg 3
Aversa 2
Bologna 2
Borås 2
Ciampino 2
Dallas 2
Durham 2
Guangzhou 2
Hamar 2
Handan 2
Melbourne 2
Milan 2
North Bergen 2
Santa Clara 2
Seattle 2
Xi'an 2
Zhoukou 2
Ardea 1
Bazhou 1
Berlin 1
Bratislava 1
Buffalo 1
Central 1
Centurion 1
Frankfurt am Main 1
Ganzhou 1
Goodyear 1
Haikou 1
Halfweg 1
Jinan 1
Las Vegas 1
Luxembourg 1
Mirabella Eclano 1
Nanchang 1
Nanyang 1
Pune 1
Riyadh 1
San Jose 1
Springfield 1
Tallinn 1
Tirana 1
Toronto 1
Turku 1
Yiwu 1
Totale 696
Nome #
Circadian variations of platelet reactivity on clopidogrel in patients treated with elective percutaneous coronary intervention 314
Takotsubo Syndrome and Coronary Artery Disease: Which Came First-The Chicken or the Egg? 56
Contrast-induced Acute Kidney Injury in Diabetic Patients and SGLT-2 Inhibitors: A Preventive Opportunity or Promoting Element? 53
Antithrombotic treatment in patients with atrial fibrillation undergoing coronary angioplasty: rational convincement and supporting evidence 47
Prediction of type 4a myocardial infarction with the angiography-derived hemodynamic (ADDED) index 44
Invasive Assessment of Coronary Microvascular Function 39
Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data 39
Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study 37
Prediction of 5-Year Mortality in Patients with Chronic Coronary Syndrome Treated with Elective Percutaneous Coronary Intervention: Role of the ACEF Score 35
Impact of burden and distribution of aortic valve calcification on the hemodynamic performance and procedural outcomes of a self-expanding, intra-annular transcatheter aortic valve system 34
Combined procedure of transcatheter aortic valve replacement and coronary intravascular lithotripsy 34
Coronary Chronic Total Occlusion Revascularization: When, Who and How? 34
Comparison of Lipid-Lowering Medications and Risk for Cardiovascular Disease in Diabetes 34
Leptin as predictor of cardiovascular events and high platelet reactivity in patients undergoing percutaneous coronary intervention 33
Designing the Optimal Procedure: Role of CT Scan in the Planning of Transcatheter Structural Heart Interventions 33
Integrating platelet reactivity in the age, creatinine and ejection fraction score to predict clinical outcomes following percutaneous coronary intervention in patients with chronic coronary syndrome: the PR-ACEF score 32
Relationship Between the Completeness of Revascularization and Myocardial Injury in Patients Treated With Percutaneous Coronary Intervention 31
Current Applications and New Perspectives in Optical Coherence Tomography (OCT) Coronary Atherosclerotic Plaque Assessment: From PCI Optimization to Pharmacological Treatment Guidance 31
Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention 31
Correlation between glycemic variability assessed by CGM and short-term outcome in patients undergoing percutaneous coronary intervention 30
Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease 30
Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation 29
Impact of oral anticoagulant regimens on occurrence of contrast-induced nephropathy in patients undergoing coronary angioplasty 28
The Pivotal Role of Invasive Functional Assessment in Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA) 27
Relation of Platelet Indexes to Platelet Reactivity and Periprocedural Myocardial Infarction in Patients Who Underwent Percutaneous Coronary Angioplasty 25
Prevalence and clinical impact of high platelet reactivity in patients with chronic kidney disease treated with percutaneous coronary intervention: An updated systematic review and meta-analysis 18
Usefulness of Adding Pre-procedural Glycemia to the Mehran Score to Enhance Its Ability to Predict Contrast-induced Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention Development and Validation of a Predictive Model 18
Ranolazine Improves Glycemic Variability and Endothelial Function in Patients with Diabetes and Chronic Coronary Syndromes: Results from an Experimental Study 17
Totale 1.213
Categoria #
all - tutte 8.218
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.218


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202235 0 0 0 0 0 0 0 0 0 1 7 27
2022/202337 2 0 2 8 5 0 1 0 0 0 19 0
2023/2024450 2 9 13 15 10 44 23 258 18 17 7 34
2024/2025691 39 8 46 20 14 43 32 8 56 134 291 0
Totale 1.213